REP 40 Pill - white capsule/oblong
Generic Name: repotrectinib
Pill with imprint REP 40 is White, Capsule/Oblong and has been identified as Augtyro 40 mg. It is supplied by Bristol-Myers Squibb Company.
Augtyro is used in the treatment of Non Small Cell Lung Cancer and belongs to the drug class multikinase inhibitors. Augtyro 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for REP 40
Augtyro
- Generic Name
- repotrectinib
- Imprint
- REP 40
- Strength
- 40 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb Company
- National Drug Code (NDC)
- 00003-4040
Related images for "REP 40"
More about Augtyro (repotrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
